iMDx
Nashville
About iMDx
iMDx is a molecular diagnostics company that develops and offers blood-based tests for oncology and transplant care. The company offers assays such as GraftAssureCore (a lab test for transplant rejection), GraftAssureIQ (a research-use kit), and DetermaIO for immunotherapy guidance. The company holds CLIA and state lab certifications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $138.3M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2026)
- Ticker: nyse:OCX
- Website: imdxinc.com
- Phone: +1 615 255 8880
Industries & Categories
Biotechnology, Health Care, Hospital, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/imdx-95462 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.